“There’s a ton of equipment; however, our focus is looking at equipment that is critical to COVID-19 patients,” added Impastato.
The lab has a lot of experience evaluating the functionality of medical equipment in isolation containers.
Back in 2014, it tested equipment in the Transport Isolation System, better known as the TIS, which was developed in response to an Ebola outbreak in West Africa. In addition, it was involved in the early development stages of the Portable Bio-Chemical Module or PBCM, which the Air Force briefly considered until the NPC and NPCL concept became reality and Air Mobility Command began moving ahead with rapid procurement and full production of the new capability.
With the NPC and NPCL, the Air Force is getting isolation containers that can carry more patients than the TIS while keeping the aircrew and medical professionals on board the aircraft safe.
The data that is collected will be reviewed by engineers in multiple mission design series aircraft to determine any associated risks that would need further analysis before approval.
“It’s great to know that we are playing a very important and timely role in dealing with this current crisis,” said Tech. Sgt. Greyson Thompson, the lab’s NCO in charge. “We know that our work helps save lives, but it’s much easier to see that immediate impact given the current events and knowing that this device will help solve the problem.”